Economic impact of the spread of COVID-19
First written in FY2020-Q3. 3 of 11 entries say "Worsened", first in FY2021-Q2. Latest entry: FY2023-Q3.
Daito Pharmaceutical moved to the "Worse" side of this theme in 2020, the same year as the typical company in this theme.
The whole theme swung hardest in 2020: 112 of 175 companies on the "Worse" side.
35 other companies' latest entry also says "Restated".
- FY2023-Q3RestatedAnnual report
「The impact of the COVID-19 pandemic on the nine months ended the third quarter of the current consolidated fiscal year was limited.」
The Company explains that, although the COVID-19 pandemic continues, its impact on the Group during the nine months ended the third quarter of the current consolidated fiscal year was limited. - FY2023-Q1MitigatedAnnual report
「The impact of the COVID-19 pandemic on the six months ended the first quarter of the current consolidated fiscal year was limited.」
The Company states that, although the COVID-19 pandemic continues, its impact on the Group during the six months ended the first quarter of the current consolidated fiscal year was limited. - FY2022MitigatedAnnual report
「The impact of the COVID-19 pandemic on the current consolidated fiscal year was limited.」
The Company explains that, although the COVID-19 pandemic continues, its impact on the Group during the current consolidated fiscal year was limited. - FY2022-Q3WorsenedAnnual report
「During the nine months ended the third quarter of the current consolidated fiscal year, economic activity had begun to recover as COVID-19 vaccinations progressed, but the outlook remained uncertain due to the renewed spread of infections involving new variants.」
The Company acknowledges signs of recovery due to vaccinations, while identifying the renewed spread of infections involving new variants as a factor contributing to economic uncertainty. It also states that the impact on the Group during the current year-to-date period was limited. - FY2022-Q2WorsenedAnnual report
「During the six months ended the second quarter of the current consolidated fiscal year, the Japanese economy remained in a difficult situation due to the impact of the spread of COVID-19. Although economic activity recovered as vaccinations became more widespread and the economy showed signs of a moderate recovery, the outlook remained uncertain, including due to continued concerns about the renewed spread of infections.」
The Company acknowledges signs of recovery due to vaccinations, while describing the difficult economic conditions and concerns about a renewed spread of infections. It also states that the impact on the Group during the current year-to-date period was limited. - FY2022-Q1RestatedAnnual report
「The impact of the COVID-19 pandemic on the six months ended the first quarter of the current consolidated fiscal year was limited.」
The Company states that, although the COVID-19 pandemic continues, its impact on the Group during the three months ended the first quarter of the current consolidated fiscal year was limited. - FY2021-Q3RestatedAnnual report
「During the nine months ended the third quarter of the current consolidated fiscal year, the Japanese economy remained in a difficult situation due to the impact of the spread of COVID-19. Although economic activity gradually resumed and showed signs of a moderate recovery, restrictions on activity were also imposed in response to the renewed spread of infections, and the outlook remained uncertain. The impact of the COVID-19 pandemic on the nine months ended the third quarter of the current consolidated fiscal year was limited.」
The Company continues to describe the difficult and uncertain economic environment resulting from the renewed spread of infections and restrictions on activity, while stating that the impact on the Group during the current year-to-date period was limited. - FY2021-Q2WorsenedAnnual report
「During the six months ended the second quarter of the current consolidated fiscal year, the Japanese economy remained in a difficult situation due to the impact of the spread of COVID-19. Although economic activity gradually resumed and showed signs of a moderate recovery, infections were beginning to spread again and the outlook remained uncertain. The impact of the COVID-19 pandemic on the six months ended the second quarter of the current consolidated fiscal year was limited.」
The Company describes the difficult economic environment and uncertain outlook resulting from the renewed spread of infections, while stating that the impact on the Group during the six months ended the second quarter of the current consolidated fiscal year was limited. - FY2021-Q1MaterialisedAnnual report
「The impact of the COVID-19 pandemic on the six months ended the first quarter of the current consolidated fiscal year was limited.」
The Company states that the COVID-19 pandemic actually occurred and had a limited impact on the six months ended the first quarter of the current consolidated fiscal year. - FY2020MaterialisedAnnual report
「The impact of the COVID-19 pandemic on the current consolidated fiscal year was limited.」
The Company states that the COVID-19 pandemic actually occurred and had a limited impact on the current consolidated fiscal year. - FY2020-Q3First statedAnnual report
「The outlook remains uncertain, as the spread of COVID-19 is expected to affect the Japanese and global economies.」
The Company mentions for the first time the risk posed by the impact of the spread of COVID-19 on the Japanese and global economies.